A total of 258 patients with obscure gastrointestinal bleeding were referred for small bowel enteroscopy, a procedure which allows endoscopic evaluation of most of the small intestine. A small bowel tumour was found in 5% of patients. In 50% of patients no diagnosis could be made, but when the cause of obscure bleeding was discovered small bowel tumours were the single most common lesion in patients younger than 50 years. Small bowel tumours causing gastrointestinal bleeding may remain undetected despite extensive diagnostic evaluation. We conclude that small bowel tumours are the most common cause of obscure gastrointestinal bleeding in patients less than 50 years of age. Small bowel enteroscopy is diagnostic of small bowel tumours even when all previous diagnostic studies, including enteroclysis and angiography, are negative.
Methods
The endoscope used is 2560 mm long and has a 5 mm tip diameter (SIF-SW, Olympus, New Hyde Park, New York, USA). It has a forward view of 1200 but no deflectional or therapeutic capability. 4 The small bowel enteroscope has two internal channels, one for air inflation and one for balloon at the instrument's tip that acts as a bolus for peristaltic action. The technique of small bowel enteroscopy has been described previously.5 Initially, the enteroscope is passed transnasally into the stomach. A paediatric colonoscope is then passed orally and advanced into the jejunum, an examination called 'push' enteroscopy. The paediatric colonoscope or 'push' enteroscope is then withdrawn into the stomach and used to position the small bowel enteroscope in the small intestine. A suture affixed to the enteroscope's tip is grasped and both instruments are advanced in the jejunum. Peristalsis then carries the small bowel enteroscope distally. Passage time averages eight hours with 77% of examinations reaching the distal ileum or beyond into the colon. Endoscopic examination of the small intestine is performed on instrument withdrawal, which averages 45-60 minutes.
A total of 258 patients with obscure gastro- Age (by decade) pre-examination enteroclysis studies in four patients failed to show these small bowel tumours. In seven patients angiography before small bowel enteroscopy was also nondiagnostic.
When patients with obscure bleeding were divided according to age, 3% (6/207) of patients over the age of 50 years had a small bowel tumour, while 14% (7/51) under 50 had a small bowel tumour (p=0 006). The incidence of small bowel tumours related to age is shown in Figure  2A . The age/tumour relation contrasts distinctly with the major diagnostic group, arteriovenous malformations, which increased with increasing age into the ninth decade ( Fig 2B) . Arteriovenous malformations of the small intestine were the most common finding at enteroscopy and occurred in 40% of patients (Table II) . When patients with small bowel tumours are compared with patients with arteriovenous malformations only age and the number of units of blood transfused distinguished these two groups (Table III 20 30 U 1 11"""""""""""""""""""""""""""""""""""',"""""""""""""""""""""""
group.bmj.com on November 7, 2017 -Published by http://gut.bmj.com/ Downloaded from common finding, accounting for 80% of causes discovered. Small bowel tumours were the second most common cause of obscure gastrointestinal bleeding, accounting for 10% of findings or 5% of all patients. This is similar to the 7% incidence described by Thompson et al. "9 In other series ofpatients with small bowel tumours obscure bleeding was also often the only presenting symptom, which contributed to the difficulty in establishing the diagnosis. Bleeding as the presenting complaint occurs in 25-53% of patients with small bowel tumours.2322 Since the sole presentation ofa small bowel tumour may be obscure bleeding the diagnosis is often delayed, contributing to the poor prognosis in patients with malignant small bowel tumours.23 24 Routine small bowel series and angiography may not detect small bowel tumours.2>27 Enteroclysis is a double contrast study of the small bowel, performed using barium and methylcellulose as contrast agents injected through a tube passed orally into the duodenum. Enteroclysis has been recommended for patients with suspected small bowel tumours, since the diagnostic yield may be as high as 10% of patients with obscure gastrointestinal bleeding. 27 Even a carefully performed enteroclysis may miss a small bowel tumour, as shown by the neoplasms we found in patients with negative x ray studies.
Small bowel enteroscopy permits direct visual examination ofthe small bowel, but this visualisation is not complete. The instrument is limited in its mucosal visualisation, secondary to the lack of total small bowel intubation in all examinations, the lack of tip deflection capability, and occasional uncontrolled instrument withdrawal. Approximately 50-70% of small bowel mucosa is observed during a standard examination according to previous estimates.3 Early evaluation of small bowel enteroscopy suggested that the examination may miss isolated, non-actively bleeding polyps or tumours of the small bowel.2 This has occurred in two young patients with normal enteroscopy who were referred for exploratory laparotomy because of continuing obscure bleeding and were found to have a small bowel tumour. In one, a leiomyoma was missed in the jejunum, and in the second, the lesion was not reached by the enteroscope.
Patients with small bowel tumours are relatively young compared with patients with other causes of obscure gastrointestinal bleeding. The mean age of our patients with small bowel tumours was 51 years, which is similar to that in previous reports. We conclude that small bowel enteroscopy may be diagnostic of small bowel tumours even when all previous diagnostic studies, including enteroclysis and angiography, are negative. Earlier concerns with the present state of endoscopic instrumentation suggesting that enteroscopy may not be diagnostic for isolated tumours seems less important.
